A Closer Look at Eli Lilly’s Announcement: PBM Scrutiny and Reputational Currency

Chris Miller on March 10, 2023

Last week, Lilly announced a 70% price reduction for its most prescribed insulins and implemented caps to patient out-of-pocket (OOP) costs at $35 or less per month.